Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update by Douglas B Johnson, Kylie Fletcher

Get full text

COVID-19 and immune checkpoint inhibitors: initial considerations by Brian I Rini, Douglas B Johnson, Javid J Moslehi, Tomas G Neilan, Christine M Lovly

Get full text

Adult Neuroblastoma Complicated by Increased Intracranial Pressure: A Case Report and Review of the Literature by Patrick L. Stevens, Douglas B. Johnson, Mary Ann Thompson, Vicki L. Keedy, Haydar A. Frangoul, Kristen M. Snyder

Get full text

Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma by Grant R Williams, Douglas B Johnson, Arissa C Young, Henry T Quach, Haocan Song, Elizabeth J Davis, Javid J Moslehi, Fei Ye

Get full text

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis by Melissa Lumish, Ryan J. Sullivan, Douglas B. Johnson, Michael Dougan, Anita Giobbie-Hurder, Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Tianqi Chen

Get full text

Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management by Julie R Brahmer, Patrick M Forde, Jarushka Naidoo, Mizuki Nishino, David Feller-Kopman, Karthik Suresh, Joshua E Reuss, Seema Mehta Steinke, Clare Rock, Douglas B Johnson

Get full text

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data by Sean Khozin, Elad Sharon, Michael Dougan, Osama Rahma, Douglas B Johnson, Leyre Zubiri, Meghan E Sise, Shaily Arora, Ravikumar Komandur Elayavilli, Aakanksha Khandelwal, Mace Rothenberg, Laura Petrillo, Alexandra-Chloe Villani

Get full text

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations by Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson

Get full text

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors by Andrew L Mammen, Jarushka Naidoo, Divyanshu Dubey, Michael Dougan, Teilo H Schaller, Meghan J Mooradian, Douglas B Johnson, Jorg Dietrich, Leyre Zubiri, Tomas G Neilan, Bianca D Santomasso, Allison Betof Warner, Justine V Cohen, Nancy Wang, Jenny Linnoila, Jeffrey M Gelfand, Anthony A Amato, Stacey L Clardy, David A Reardon, William C Louv, Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Priscilla K Brastianos, Tracey A Cho, Christopher T Doughty, Jeffrey T Guptill, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Maria Martinez-Lage, Krista M Rubin, Karin Woodman

Get full text

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy by Laura C Cappelli, Bernice Kwong, Jarushka Naidoo, Jonathan Leventhal, Mario E Lacouture, Meghan J Mooradian, Douglas B Johnson, Justine Cohen, Aparna Hegde, Steven T Chen, Riley Fadden, Leyre Zubiri, Shawn Kwatra, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Yevgeniy R Semenov, Nicole R LeBoeuf, Krista M Rubin, Anna K Dewan, Alina Markova, Allireza Alloo, Daniel Q Bach, Amina Bougrine, Leeann Burton, Mariana Castells, Lauren Guggina, Victor Huang, Benjamin Kaffenberger, Daniela Kroshinsky, Cecilia Larocca, Jon McDunn, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Maxwell Sauder, Sheila Shaigany, Afreen Shariff

Get full text